Vitura Health has announced the departure of CEO Geoff Cockerill, appointing Chief Revenue Officer Ryan Tattle as interim leader while accelerating the search for a new CEO. Incoming CFO Andrew Cook will join ahead of schedule, signalling a renewed focus on operational and financial discipline.
- CEO Geoff Cockerill departs effective 28 January 2026
- Ryan Tattle assumes interim CEO responsibilities
- Shane Tanner appointed Interim Executive Director to support leadership
- New CFO Andrew Cook starts earlier than planned on 9 February 2026
- Company maintains focus on strategic priorities in digital health and medicinal cannabis
Leadership Transition at Vitura Health
Vitura Health Limited (ASX – VIT) has announced a significant leadership change with the departure of CEO Geoff Cockerill, effective from 28 January 2026. The Board expressed gratitude for Mr Cockerill's contributions but emphasised the need for new leadership to accelerate the execution of the company's strategic priorities amid ongoing efforts to improve financial and operational performance.
In the interim, Chief Revenue Officer Ryan Tattle has stepped up to manage day-to-day operations, bringing with him extensive commercial experience and a deep understanding of Vitura’s growth strategy. This move ensures continuity while the Board conducts a prioritised search for a permanent CEO focused on execution and transformation.
Supporting the Interim Leadership
To bolster the interim leadership team, Non-Executive Director Shane Tanner has taken on the role of Interim Executive Director. Mr Tanner will collaborate closely with Mr Tattle to drive operational and performance improvements. His appointment, effective immediately, is set to last until at least the end of April 2026, with potential extensions depending on the CEO appointment timeline.
Accelerated CFO Appointment
In a further sign of the company’s commitment to financial discipline, Vitura confirmed that incoming Chief Financial Officer Andrew Cook will commence earlier than expected, starting on 9 February 2026. Mr Cook brings over two decades of international finance experience across diverse industries, including senior roles at Energy Queensland, Origin Energy, and AnteoTech Limited. His early arrival is likely to support the company’s strategic reset and operational excellence initiatives.
Strategic Focus Amid Change
Despite the leadership shuffle, Vitura remains steadfast in its strategic priorities. The company continues to develop its digital health platforms and medicinal cannabis operations, including its Canview ecosystem, telehealth services, and joint ventures in psychedelic product distribution. Chair Robert Iervasi reiterated the company’s focus on operational excellence, financial discipline, and strengthening its position as a trusted healthcare services provider.
Vitura’s diversified portfolio spans telehealth platforms, medicinal cannabis clinics, and innovative digital health solutions, positioning it well to capitalise on emerging opportunities in healthcare technology and regulated therapeutics.
Bottom Line?
As Vitura Health navigates this leadership transition, all eyes will be on the new CEO appointment and how swiftly the company can translate strategic ambitions into tangible results.
Questions in the middle?
- Who will be the new CEO and what experience will they bring to drive Vitura’s transformation?
- How will the interim leadership team manage operational challenges during this transition period?
- What impact will the early arrival of the new CFO have on financial strategy and reporting?